289 related articles for article (PubMed ID: 31334700)
1. The impact of infection and inflammation in oncologic
Rahman WT; Wale DJ; Viglianti BL; Townsend DM; Manganaro MS; Gross MD; Wong KK; Rubello D
Biomed Pharmacother; 2019 Sep; 117():109168. PubMed ID: 31334700
[TBL] [Abstract][Full Text] [Related]
2. Patient Preparation and Patient-related Challenges with FDG-PET/CT in Infectious and Inflammatory Disease.
Hess S; Scholtens AM; Gormsen LC
PET Clin; 2020 Apr; 15(2):125-134. PubMed ID: 32145883
[TBL] [Abstract][Full Text] [Related]
3. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
4. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.
Lawal I; Sathekge M
Br Med Bull; 2016 Dec; 120(1):55-74. PubMed ID: 27613996
[TBL] [Abstract][Full Text] [Related]
5. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A Comparative analysis.
Rabkin Z; Israel O; Keidar Z
J Nucl Med; 2010 Jul; 51(7):1015-20. PubMed ID: 20554733
[TBL] [Abstract][Full Text] [Related]
6. Expert Consensus on clinical application of FDG PET/CT in infection and inflammation.
Li Y; Wang Q; Wang X; Li X; Wu H; Wang Q; Yao Z; Miao W; Zhu X; Hua F; Zhang X; Cheng C; Zhang W; Hou Q; Li Y; Li XF
Ann Nucl Med; 2020 May; 34(5):369-376. PubMed ID: 32086761
[TBL] [Abstract][Full Text] [Related]
7. Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin.
Mulders-Manders CM; Kouijzer IJ; Janssen MJ; Oyen WJ; Simon A; Bleeker-Rovers CP
Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):51-58. PubMed ID: 31271266
[TBL] [Abstract][Full Text] [Related]
8. Febrile syndrome of unknown origin: Indications for
García JR
Radiologia; 2017; 59(3):253-263. PubMed ID: 27671947
[TBL] [Abstract][Full Text] [Related]
9. Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation.
Pijl JP; Nienhuis PH; Kwee TC; Glaudemans AWJM; Slart RHJA; Gormsen LC
Semin Nucl Med; 2021 Nov; 51(6):633-645. PubMed ID: 34246448
[TBL] [Abstract][Full Text] [Related]
10. Benign Cutaneous and Subcutaneous Lesions on FDG-PET/CT.
Metser U; Tau N
Semin Nucl Med; 2017 Jul; 47(4):352-361. PubMed ID: 28583275
[No Abstract] [Full Text] [Related]
11. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
[TBL] [Abstract][Full Text] [Related]
12. Combined clinical parameters improve the diagnostic efficacy of
Wang WX; Cheng ZT; Zhu JL; Xing MY; Zheng CF; Wang SJ; Xie NN; XianYu ZQ; Song JX
Int J Infect Dis; 2020 Apr; 93():77-83. PubMed ID: 31982625
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography can reliably rule-out infection and cancer in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis suspected of disease relapse.
Frary EC; Hess S; Gerke O; Laustrup H
Medicine (Baltimore); 2017 Jul; 96(30):e7613. PubMed ID: 28746217
[TBL] [Abstract][Full Text] [Related]
14. Pictorial review of
Ishibashi M; Tanabe Y; Fujii S; Ogawa T
Ann Nucl Med; 2017 Jul; 31(6):437-453. PubMed ID: 28585058
[TBL] [Abstract][Full Text] [Related]
15. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Oncologic
Montilla-Soler JL; Makanji RJ; Barron BJ
Am J Med; 2018 Apr; 131(4):357-364. PubMed ID: 29274757
[TBL] [Abstract][Full Text] [Related]
18. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic accuracy of
Lemans JVC; Hobbelink MGG; IJpma FFA; Plate JDJ; van den Kieboom J; Bosch P; Leenen LPH; Kruyt MC; Glaudemans AWJM; Govaert GAM
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):999-1008. PubMed ID: 30523391
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of
Treglia G
Contrast Media Mol Imaging; 2019; 2019():3018349. PubMed ID: 31427907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
